FIND PHARMACEUTICALS

Breast Cancer





Tykerb® Generic
(Lapatinib)

Contact for Price
Get a Quote
X

LAPATINIBGet a Quote


Product Description - Chemotherapy Drug used in the treatment of advanced or metastatic breast cancer and other solid tumours. Dual Tyrosine kinase inhibitor which interrupts the HER2/neu and epidermal growth factor receptor (EGFR) pathways.

Details
  • Brand Name: Tykerb®
  • Generic Name: LAPATINIB
  • Dosage Form: Tablets in bottle.
  • Retail Pack: Pack of 28 Tablets
  • Manufacturer Name: GlaxoSmithKline (GSK)

Price
Contact for Quote

Treatment
PO- The recommended dose is 1,250 mg (5 tablets) given orally once daily on days 1-21 continuously in combination with capecitabine 2,000 mg/m2/day. Please discuss the dosage with your doctor and only take under their direction.

Warnings and Precaustions
Caution should be exercised in patients with history of liver, lung, heart disease, irregular heartbeat, low blood electrolyte levels, bone marrow depression, any allergy, children, during pregnancy and breastfeeding.

Monitor liver function, heart function, and complete blood cell counts regularly while taking this medication.

Do not take if Pregnant.
Do not take if Hypersensitive.
Side Effects
  • Gastrointestinal - Diarrhea, mouth ulcer, indigestion, nausea and vomiting
  • Skin - Rash, dry skin, hand and foot syndrome
  • Musculoskeletal - Pain in extremities and back pain
  • Respiratory - Difficulty in breathing
  • Centeral Nervous System - Sleeplessness
Requirements
Doctor Prescription is required.

About the Manufacturer
The manufacturer is NATCO Pharma based in India with additional plants in Australia, Brazil and Canada. NATCO can be found on the NSE and BSE stock exchanges and provide pharmaceuticals in many specialty areas.



Lung & Pancreatic Cancer



Erlotinib® Generic
(Erlocip)

Contact for Price
Get a Quote
X

ERLOCLIPGet a Quote


Product Description -
Non-small cell lung cancer (NSCLC) - Erlotinib hydrochloride is used as first-line treatment for metastatic NSCLC in patients with tumors that have certain epidermal growth factor receptor (EGFR) mutations.
Pancreatic® Cancer - Erlocip (Erlotinib hydrochloride) is used with gemcitabine hydrochloride in patients whose disease cannot be removed by surgery or has metastasized.
Details
  • Brand Name: Erlotinib®
  • Generic Name: ERLOCLIP
  • Dosage Form: Tablets in bottle.
  • Retail Pack: Pack of 30 Tablets
  • Manufacturer Name: CIPLA, LTD.

Price
Contact for Price

Treatment
Non-small cell lung carcinoma
150 mg once daily until disease progression or unacceptable toxicity. Reduce dose in decrements of 50 mg when necessary. Please discuss the dosage with your doctor and only take under their direction.

Metastic pacreatic cancer
As 1st-line treatment with gemcitabine: 100 mg once daily, reduce dose in decrements of 50 mg when necessary. Please discuss the dosage with your doctor and only take under their direction.

Requirements
Doctor Prescription is required.

About the Manufacturer
Incorporated in 1935, Cipla has become one of the top pharmaceutical companies in India, headquartered in Mumbai, India with facilities in Goa, Bengaluru, Baddi, Indore, Kurkumbh, Patalganga and Sikkim. Cipla primarily develops medicines to treat cardiovascular disease, arthritis, diabetes, weight control and depression; other medical conditions.



How It Works - When you choose a drug and click "GET A QUOTE" you will be taken to a contact form that will submit your request directly to Genetec LifeSciences. The form will ask you to upload your prescription with the request. They will then work directly with you and the pharmaceutical company to fulfill your order.




Prostate Cancer



Zytiga® Generic
(ZECYTE)

Contact for Price
Get a Quote
X

ZECYTEGet a Quote


Product Description -
ZECYTE is the Generic Version of Zytiga® (Abiraterone Acetate)

ZECYTE 250mg – Abiraterone Acetate is a drug used in combination with prednisone in metastatic castration-resistant prostate cancer (formerly hormone-resistant prostate cancer) which is a prostate cancer not responding to androgen deprivation or treatment with anti-androgens

Details
  • Brand Name: Zytiga®
  • Generic Name: ZECYTE
  • Ingredients: Abiraterone Acetate 250MG
  • Dosage Form: Tablets in bottle.
  • Retail Pack: Pack of 120 Tablets
  • Manufacturer Name: CIPLA, LTD.

Price
Contact for Price

Treatment
ZECYTE (Abiraterone acetate) is a pill, taken by mouth. It is taken once a day. ZECYTE must be taken on an empty stomach [2 hours after a meal, or one hour before]. ZECYTE should be taken at approximately the same time each day.

Prednisone [10mg daily] should be taken along with ZECYTE (Abiraterone acetate).

Warnings and Precaustions
The amount of ZECYTE (Abiraterone acetate) you receive depends on many factors. Your doctor must determine your dose and schedule.

ZECYTE (Abiraterone acetate) works by inhibiting specific “enzymes” in your adrenal glands that are responsible for making androgens. For this reason, there is an increased risk of over production of mineralcorticosteroids in your body while on ZECYTE(Abiraterone acetate). As a result, ZECYTE (Abiraterone acetate) may cause hypertension [high blood pressure], hypokalemia [low levels of potassium in the blood], and fluid retention.

Because of this risk, ZECYTE (Abiraterone acetate) should be used cautiously in patients with a strong cardiovascular history, and patients should be monitored closely for these symptoms. Dosing along with prednisone will decrease the risk of mineralocorticoid excess.

Requirements
Doctor Prescription is required.

About the Manufacturer
Incorporated in 1935, Cipla has become one of the top pharmaceutical companies in India, headquartered in Mumbai, India with facilities in Goa, Bengaluru, Baddi, Indore, Kurkumbh, Patalganga and Sikkim. Cipla primarily develops medicines to treat cardiovascular disease, arthritis, diabetes, weight control and depression; other medical conditions.



Thyriod, Renal Cell & HCC





Nexavar® Generic
(Soranib)

Contact for Price
Get a Quote
X

SORANIBGet a Quote


Product Description -
SORANIB is the Generic Version of Nexavar®

SORANIB (Sorafenib) a cancer medication that interferes with the growth and spread of cancer cells in the body. SORANIB (Sorafenib) Nexavar Generic is used to treat:
  • Treatment of advance renal cell cancer
  • Hepatocellular carcinoma (HCC)
  • Thyroid cancer
Details
  • Brand Name: Nexavar®
  • Generic Name: SORANIB
  • Ingredients: Sorafenib 200MG
  • Dosage Form: 30 & 120 Tablets in bottle.
  • Manufacturer Name: CIPLA, LTD.

Price
Contact for Price

Treatment
The recommended daily dose of SORANIB (Sorafenib) Nexavar Generic Tablets is 400 mg (2 x 200 mg tablets) taken twice daily without food (at least 1 hour before or 2 hours after a meal). Treatment should continue until the patient is no longer clinically benefiting from therapy or until unacceptable toxicity occurs.

Warnings and Precaustions
The amount of Soranib you receive depends on many factors. Your doctor must determine your dose and schedule and be managed under strict medical supervision.

You should not use SORANIB (Sorafenib) if you have squamous cell lung cancer and you are being treated with carboplatin (Paraplatin) and paclitaxel (Onxol, Taxol, Abraxane). SORANIB (Sorafenib) can cause heart problems. Stop taking this medicine and call your doctor at once if you have chest pain and severe dizziness, fainting, sweating, or feeling short of breath. SORANIB (Sorafenib)can also cause severe bleeding. Call your doctor if you have blood in your urine or stools, abnormal vaginal bleeding, severe stomach pain, coughing up blood, or any bleeding that will not stop.

Requirements
Doctor Prescription is required.

About the Manufacturer
Incorporated in 1935, Cipla has become one of the top pharmaceutical companies in India, headquartered in Mumbai, India with facilities in Goa, Bengaluru, Baddi, Indore, Kurkumbh, Patalganga and Sikkim. Cipla primarily develops medicines to treat cardiovascular disease, arthritis, diabetes, weight control and depression; other medical conditions.


What is listed here is just a portion of what is available. If you do not see a pharmaceutical drug that you need, please contact Genetec LifeSciences here.